目的 探讨重组人粒细胞巨噬细胞集落刺激因子(rhGM-CSF)凝胶对糖尿病大鼠创面愈合及创面组织中微小RNA表达的影响. 方法 取18只雄性清洁级SD大鼠建立糖尿病模型.4周后取稳定成模的16只糖尿病大鼠,于背部两侧制作4个全层皮肤缺损创面,共64个创面.采用配对设计以脊柱两侧对称的创面配对,采用盲法(用红蓝两色标识rhGM-CSF或凝胶基质)及随机数字表法分为2组,每组32个创面;A组采用红色标签药剂、B组采用蓝色标签药剂.2组大鼠均每日涂抹药膏1次,厚度为3 mm,至伤后14d.伤后3、7、14d,大体观察各组创面愈合情况;计算伤后3、7d创面愈合率.伤后3、7、14d,每组分别采集2、4、8个创面标本行HE染色观察组织病理学改变,免疫组织化学染色检测创面CD31和增殖细胞核抗原(PCNA)表达(数据以吸光度值表示).伤后7d每组另采集6个创面组织样本行芯片检测,筛选差异表达明显的微小RNA,经实时荧光定量RT-PCR验证后行京都基因和基因组百科全书(KEGG)信号通路功能富集分析.对数据行配对样本t检验或两样本t检验. 结果 (1)伤后3d,2组创面面积均明显缩小,肉芽组织增生明显.伤后7d,2组创面均进一步缩小,创腔基本被肉芽组织填平;A组创面缩小更明显,肉芽组织量多.伤后14d,A组创面基本愈合;B组部分创面仍存在少许创腔及结痂.伤后3、7d,A组创面愈合率分别为(41±5)%和(75±4)%,明显高于B组的(31±9)%和(71±4)%(t值分别为10.13、8.06,P值均小于0.001).(2)伤后3d,2组创面表皮细胞、内皮细胞、Fb均排列稀疏,炎性细胞大量浸润.其中A组创面上述表现优于B组.伤后7d,A组创面表皮细胞、内皮细胞、Fb排列渐致密,炎性细胞浸润稍多于B组.伤后14 d,A组表皮完全覆盖创面,B组部分创面仍有炎性浸润.(3)伤后3、7、14 d,A组创面CD31和PCNA阳性表达(0.275 ±0.018、0.345±0.034、0.305±0.023,0.406±0.063、0.223±0.011、0.045±0.022)均较B组(0.222±0.020、0.229 ±0.018、0.197 ±0.015,0.324 ±0.039、0.162±0.012、0.018 ±0.020)明显(t值为2.281~9.652,P<0.05或P<0.01).(4)微小RNA芯片检测筛选,与B组比较,A组创面组织中上调的微小RNA有18个、下调的有13个.(5)实时荧光定量RT-PCR的验证结果与芯片检测结果较一致.(6)KEGG信号通路功能富集分析显示31个差异表达明显的微小RNA中有4个参与MAPK信号途径,3个参与Wnt信号途径,1个参与TGF-β信号途径,3个参与表皮生长因子受体信号途径,2个参与细胞周期途径,5个参与轴突导向信号途径,6个参与黏着斑途径,3个参与肌动蛋白细胞骨架途径,1个参与细胞外基质受体途径,3个参与黏着连接途径,1个参与细胞黏附分子途径.经揭肓,A组采用红色标签药剂为rhGM-CSF凝胶、B组采用蓝色标签药剂为凝胶基质. 结论 rhGM-CSF凝胶可促进糖尿病大鼠创面愈合,引起皮肤组织中微小RNA明显差异性表达,这可能是其促进创面愈合在基因转录后水平上的靶点.
目的 探討重組人粒細胞巨噬細胞集落刺激因子(rhGM-CSF)凝膠對糖尿病大鼠創麵愈閤及創麵組織中微小RNA錶達的影響. 方法 取18隻雄性清潔級SD大鼠建立糖尿病模型.4週後取穩定成模的16隻糖尿病大鼠,于揹部兩側製作4箇全層皮膚缺損創麵,共64箇創麵.採用配對設計以脊柱兩側對稱的創麵配對,採用盲法(用紅藍兩色標識rhGM-CSF或凝膠基質)及隨機數字錶法分為2組,每組32箇創麵;A組採用紅色標籤藥劑、B組採用藍色標籤藥劑.2組大鼠均每日塗抹藥膏1次,厚度為3 mm,至傷後14d.傷後3、7、14d,大體觀察各組創麵愈閤情況;計算傷後3、7d創麵愈閤率.傷後3、7、14d,每組分彆採集2、4、8箇創麵標本行HE染色觀察組織病理學改變,免疫組織化學染色檢測創麵CD31和增殖細胞覈抗原(PCNA)錶達(數據以吸光度值錶示).傷後7d每組另採集6箇創麵組織樣本行芯片檢測,篩選差異錶達明顯的微小RNA,經實時熒光定量RT-PCR驗證後行京都基因和基因組百科全書(KEGG)信號通路功能富集分析.對數據行配對樣本t檢驗或兩樣本t檢驗. 結果 (1)傷後3d,2組創麵麵積均明顯縮小,肉芽組織增生明顯.傷後7d,2組創麵均進一步縮小,創腔基本被肉芽組織填平;A組創麵縮小更明顯,肉芽組織量多.傷後14d,A組創麵基本愈閤;B組部分創麵仍存在少許創腔及結痂.傷後3、7d,A組創麵愈閤率分彆為(41±5)%和(75±4)%,明顯高于B組的(31±9)%和(71±4)%(t值分彆為10.13、8.06,P值均小于0.001).(2)傷後3d,2組創麵錶皮細胞、內皮細胞、Fb均排列稀疏,炎性細胞大量浸潤.其中A組創麵上述錶現優于B組.傷後7d,A組創麵錶皮細胞、內皮細胞、Fb排列漸緻密,炎性細胞浸潤稍多于B組.傷後14 d,A組錶皮完全覆蓋創麵,B組部分創麵仍有炎性浸潤.(3)傷後3、7、14 d,A組創麵CD31和PCNA暘性錶達(0.275 ±0.018、0.345±0.034、0.305±0.023,0.406±0.063、0.223±0.011、0.045±0.022)均較B組(0.222±0.020、0.229 ±0.018、0.197 ±0.015,0.324 ±0.039、0.162±0.012、0.018 ±0.020)明顯(t值為2.281~9.652,P<0.05或P<0.01).(4)微小RNA芯片檢測篩選,與B組比較,A組創麵組織中上調的微小RNA有18箇、下調的有13箇.(5)實時熒光定量RT-PCR的驗證結果與芯片檢測結果較一緻.(6)KEGG信號通路功能富集分析顯示31箇差異錶達明顯的微小RNA中有4箇參與MAPK信號途徑,3箇參與Wnt信號途徑,1箇參與TGF-β信號途徑,3箇參與錶皮生長因子受體信號途徑,2箇參與細胞週期途徑,5箇參與軸突導嚮信號途徑,6箇參與黏著斑途徑,3箇參與肌動蛋白細胞骨架途徑,1箇參與細胞外基質受體途徑,3箇參與黏著連接途徑,1箇參與細胞黏附分子途徑.經揭肓,A組採用紅色標籤藥劑為rhGM-CSF凝膠、B組採用藍色標籤藥劑為凝膠基質. 結論 rhGM-CSF凝膠可促進糖尿病大鼠創麵愈閤,引起皮膚組織中微小RNA明顯差異性錶達,這可能是其促進創麵愈閤在基因轉錄後水平上的靶點.
목적 탐토중조인립세포거서세포집락자격인자(rhGM-CSF)응효대당뇨병대서창면유합급창면조직중미소RNA표체적영향. 방법 취18지웅성청길급SD대서건립당뇨병모형.4주후취은정성모적16지당뇨병대서,우배부량측제작4개전층피부결손창면,공64개창면.채용배대설계이척주량측대칭적창면배대,채용맹법(용홍람량색표식rhGM-CSF혹응효기질)급수궤수자표법분위2조,매조32개창면;A조채용홍색표첨약제、B조채용람색표첨약제.2조대서균매일도말약고1차,후도위3 mm,지상후14d.상후3、7、14d,대체관찰각조창면유합정황;계산상후3、7d창면유합솔.상후3、7、14d,매조분별채집2、4、8개창면표본행HE염색관찰조직병이학개변,면역조직화학염색검측창면CD31화증식세포핵항원(PCNA)표체(수거이흡광도치표시).상후7d매조령채집6개창면조직양본행심편검측,사선차이표체명현적미소RNA,경실시형광정량RT-PCR험증후행경도기인화기인조백과전서(KEGG)신호통로공능부집분석.대수거행배대양본t검험혹량양본t검험. 결과 (1)상후3d,2조창면면적균명현축소,육아조직증생명현.상후7d,2조창면균진일보축소,창강기본피육아조직전평;A조창면축소경명현,육아조직량다.상후14d,A조창면기본유합;B조부분창면잉존재소허창강급결가.상후3、7d,A조창면유합솔분별위(41±5)%화(75±4)%,명현고우B조적(31±9)%화(71±4)%(t치분별위10.13、8.06,P치균소우0.001).(2)상후3d,2조창면표피세포、내피세포、Fb균배렬희소,염성세포대량침윤.기중A조창면상술표현우우B조.상후7d,A조창면표피세포、내피세포、Fb배렬점치밀,염성세포침윤초다우B조.상후14 d,A조표피완전복개창면,B조부분창면잉유염성침윤.(3)상후3、7、14 d,A조창면CD31화PCNA양성표체(0.275 ±0.018、0.345±0.034、0.305±0.023,0.406±0.063、0.223±0.011、0.045±0.022)균교B조(0.222±0.020、0.229 ±0.018、0.197 ±0.015,0.324 ±0.039、0.162±0.012、0.018 ±0.020)명현(t치위2.281~9.652,P<0.05혹P<0.01).(4)미소RNA심편검측사선,여B조비교,A조창면조직중상조적미소RNA유18개、하조적유13개.(5)실시형광정량RT-PCR적험증결과여심편검측결과교일치.(6)KEGG신호통로공능부집분석현시31개차이표체명현적미소RNA중유4개삼여MAPK신호도경,3개삼여Wnt신호도경,1개삼여TGF-β신호도경,3개삼여표피생장인자수체신호도경,2개삼여세포주기도경,5개삼여축돌도향신호도경,6개삼여점착반도경,3개삼여기동단백세포골가도경,1개삼여세포외기질수체도경,3개삼여점착련접도경,1개삼여세포점부분자도경.경게황,A조채용홍색표첨약제위rhGM-CSF응효、B조채용람색표첨약제위응효기질. 결론 rhGM-CSF응효가촉진당뇨병대서창면유합,인기피부조직중미소RNA명현차이성표체,저가능시기촉진창면유합재기인전록후수평상적파점.
Objective To investigate the effects of recombinant human granulocyte macrophage colony-stimulating factor (rhGM-CSF) on wound healing and microRNA expression in diabetic rats.Methods Eighteen male SD rats of clean grade were used to reproduce diabetes model.Four weeks later,a total of 64 full-thickness skin wounds were created on the back of 16 rats with established diabetes,with 4 wounds on each rat.Two symmetrical wounds on either side of the spine were created as a pair according to paired design.Then the wounds were divided into groups A and B according to the random number table and blind method (red and blue tags on the rhGM-CSF or the gel vehicle),with 32 wounds in each group.The ointment with red tag was applied on the wounds of group A and the blue one on group B.The application was conducted once a day,with a thickness of 3 mm,up to post injury day (PID) 14.Gross observation of wound healing was conducted on PID 3,7,14.The wound healing rate was determined on PID 3 and 7.On PID 3,7,14,tissues from 2,4,and 8 wounds were harvested from each group respectively for the observation of the histopathological changes with HE staining,and also for analyzing the expression of proliferating cell nuclear antigen (PCNA) and CD31 with immunohistochemical staining (denoted as absorbance value).On PID 7,tissues from 6 wounds in each group were harvested for microarray gene chip to screen the differentially expressed microRNAs.Enrichment analysis of Kyoto encyclopedia of genes and genomes (KEGG)signaling pathway on the differentially expressed microRNAs were performed after the microRNA screening results were validated by real-time fluorescent quantitative RT-PCR.Data were processed with paired t test or two-sample t test.Results (1) On PID 3,the wound area was significantly decreased,and the wound granulation was significantly proliferated in both groups.On PID 7,the wound area was further decreased,and the wound area was almost filled by granulation in both groups; the conditions in group A were better.On PID 14,all the wounds in group A were almost healed,while a small area of raw wound with incrustation still remained in some wounds of group B.On PID 3 and 7,the wound healing rates of group A were (41 ± 5)% and (75 ±4)%,significantly higher than those of group B [(31 ±9)% and (71 ±4)%,withtvalues respectively 10.13 and 8.06,P values below 0.001].(2) On PID 3,the epidermal cells,endothelial cells,and Fbs in the wounds of 2 groups were sparse,with heavy infiltration of inflammatory cells.The above condition in the wounds was better in group A than in group B.On PID 7,the epidermal cells,endothelial cells,and Fbs were gradually well arranged in group A; infiltration of inflammatory cells decreased,and the condition was better than that of group B.On PID 14,the wounds of group A were completely covered by epidermis,while infiltration of inflammatory cells still remained in some wounds of group B.(3) On PID 3,7,14,the positive expressions of CD31 and PCNA in group A were respectively 0.275 ± 0.018,0.345 ±0.034,0.305 ±0.023; 0.406 ±0.063,0.223±0.011,0.045 ±0.022.They were significantly higher than those of group B (0.222 ±0.020,0.229 ±0.018,0.197 ±0.015; 0.324 ±0.039,0.162 ± 0.012,0.018 ±0.020,with t values from 2.281 to9.652,P <0.05 orP <0.01).(4) According to the microRNAs detection and screening,as compared with group B,18 microRNAs were up-regulated while 13 were down-regulated in the wounds of group A.(5) The results of real-time fluorescent quantitative RT-PCR had good consistency with the results of microRNAs detection.(6) Enrichment analysis of KEGG signaling pathway showed that among the 31 differentially expressed microRNAs,4 took part in the MAPK signaling pathway,3 took part in the Wnt signaling pathway,1 took part in the TGF-β signaling pathway,3 took part in the epidermal growth factor receptor signaling pathway,2 took part in the cell cycle pathway,5 took part in the axon guidance signaling pathway,6 took part in the focal adhesion pathway,3 took part in the regulation of actin cytoskeleton pathway,1 took part in the extracellular cell matrix receptor pathway,3 took part in the adherens junction pathway,and 1 took part in the cell adhesion molecules pathway.After disclosing the blind,it showed that the ointment with red tag was the rhGM-CSF gel and the blue one was gel vehicle.Conclusions The rhGM-CSF gel can pronote wound healing in diabetic rats,producing significant differential microRNA expression in wounds,and they may be the target at gene post-transcriptional level of rhGM-CSF gel in promoting wound healing.